输尿管镜术后无阿片类出院不增加非计划医疗接触:全州质量改进协作结果
基于MUSIC-ROCKS前瞻性队列的回顾性分析纳入13,143例成人输尿管镜取石患者,评估术后阿片类处方相关因素及无阿片出院与30天内急诊就诊的关系。结果显示阿片类处方与急诊就诊均下降,无阿片出院与急诊就诊增加无关(OR 0.77,95%CI 0.62-0.95,P=.014),提示常规阿片类使用可能并非必要。
要点
- 输尿管镜术后阿片类处方率从86%降至39%,急诊就诊率从10%降至6%。
- 无阿片类出院未增加30天内急诊就诊风险(OR 0.77,95%CI 0.62-0.95)。
- 阿片类处方在实践和外科医生层面变异大(8%-98%和0%-98%)。
核心结论
- 输尿管镜术后未处方阿片类药物的患者急诊就诊未增加,提示该场景常规使用阿片类可能不必要。
研究设计与样本
- 回顾性分析前瞻性队列,纳入2016年6月至2019年9月MUSIC-ROCKS项目中因泌尿系结石行初次输尿管镜的18岁以上成人,共13,143例,来自28个实践、157名泌尿外科医生。
主要发现
- 术后阿片类处方率从86%降至39%(P<.001),急诊就诊率从10%降至6%(P<.001)。
- 实践层面阿片类处方率变异为8%至98%,外科医生层面为0%至98%。
- 与阿片类处方相关的患者因素包括男性、较年轻年龄和慢性疼痛史。
- 与阿片类处方相关的手术因素包括输尿管镜前后置入输尿管支架和使用通道鞘。
- 无阿片类出院与急诊就诊 odds 无增加相关(OR 0.77,95%CI 0.62-0.95,P=.014)。
临床怎么用
- 输尿管镜术后可考虑无阿片类出院策略,而不必担心增加急诊就诊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate patient factors associated with post-ureteroscopy opioid prescriptions, provider-level variation in opioid prescribing, and the relationship between opioid-free discharges and ED visits. METHODS: This is a retrospective analysis of a prospective cohort study of adults age 18 years and older who underwent primary ureteroscopy for urinary stones from June 2016 to September 2019 within the Michigan Urological Surgery Improvement Collaborative (MUSIC) Reducing Operative Complications from Kidney Stones (ROCKS) quality improvement initiative. Postoperative opioid prescription trends and variation among practices and surgeons were examined. Multivariable logistic regression models defined risk factors for receipt of opioid prescriptions. The association among opioid prescriptions and postoperative ED visits within 30 days of surgery was assessed among complete case and propensity matched cohorts, matched on all measured characteristics other than opioid receipt. RESULTS: 13,143 patients underwent ureteroscopy with 157 urologists across 28 practices. Post-ureteroscopy opioid prescriptions and ED visits declined (86% to 39%, P<.001; 10% to 6%, P<.001, respectively). Practice and surgeon-level opioid prescribing varied from 8% to 98%, and 0% to 98%, respectively. Patient-related factors associated with opioid receipt included male, younger age, and history of chronic pain. Procedure-related factors associated with opioid receipt included pre- and post-ureteroscopy ureteral stenting and access sheath use. An opioid-free discharge was not associated with increased odds of an ED visit (OR 0.77, 95% CI 0.62-0.95, P=.014). CONCLUSIONS: There was no increase in ED utilization among those not prescribed an opioid after ureteroscopy, suggesting their routine use may not be necessary in this setting.
引用
- Hawken SR, Hiller SC, Daignault-Newton S, et al. Opioid-Free Discharge is Not Associated With Increased Unplanned Healthcare Encounters After Ureteroscopy: Results From a Statewide Quality Improvement Collaborative. Urology. 2021. PMID: 34480941. doi:10.1016/j.urology.2021.07.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。